If a nutritional substance can rapidly activate PI3K/Akt/mTOR signaling-mediated muscular hypertrophy pathway and play an active role in both the number and size of the muscle fibers, it could potentially improve skeletal muscle mass or promote muscular hypertrophy, thereby acting against the age-related sarcopenia. This evidence concerns the gene AKT1 and sarcopenia.